MDEV - ETF AI Analysis
Top Page
First Trust Indxx Medical Devices ETF (MDEV)
Rating:66Neutral
Price Target:―
Positive Factors
Broad Global Exposure Within Medical Devices
Holdings spread across the U.S., Europe, and Asia help reduce the impact of weakness in any single country’s market.
Generally Positive Recent Performance
The ETF has shown steady gains over the past month, three months, and year to date, indicating supportive recent momentum.
Multiple Strong Top Holdings
Several of the largest positions, such as Globus Medical, Penumbra, Align Technology, Revvity, Thermo Fisher, and Danaher, have delivered strong year-to-date performance that supports the fund’s returns.
Negative Factors
High Sector Concentration in Health Care
With almost all assets in the health care sector, the fund is heavily exposed to swings in medical device and health-related markets.
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost options.
Mixed Performance Among Top Holdings
Some key positions, such as Intuitive Surgical and a few others with only modest gains, have lagged the stronger names and may drag on overall performance if this continues.
MDEV vs. SPDR S&P 500 ETF (SPY)
AUM1.90M
RegionGlobal
Expense Ratio0.70%
Beta0.76
IssuerFirst Trust
Inception DateJun 22, 2021
Dividend YieldN/A
Asset ClassEquity
Index TrackedIndxx Global Medical Equipment Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume343
30 Day Avg. Volume343
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
23.67Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering50
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MDEV Summary
MDEV is the First Trust Indxx Medical Devices ETF, which follows the Indxx Global Medical Equipment Index. It invests in companies that make medical devices and tools used in hospitals and clinics, from diagnostic equipment to surgical systems. Well-known holdings include Intuitive Surgical and Thermo Fisher, both leaders in medical technology. Someone might invest in MDEV to benefit from the long-term growth of health care and medical innovation, supported by aging populations and rising health spending. A key risk is that it is heavily focused on health care equipment, so its price can swing if this niche sector falls out of favor.
How much will it cost me?The First Trust Indxx Medical Devices ETF (MDEV) has an expense ratio of 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because it is actively managed to focus on a specialized niche in the health care sector, requiring more research and management effort. While it costs more, it provides targeted exposure to innovative medical device companies.
What would affect this ETF?The First Trust Indxx Medical Devices ETF (MDEV) could benefit from positive trends such as aging populations, increasing global health care spending, and ongoing advancements in medical technology, which drive demand for innovative medical devices. However, potential risks include regulatory changes, rising interest rates that could impact borrowing costs for companies in the sector, and global economic slowdowns that may reduce health care budgets. As a globally focused ETF with exposure to leading medical device companies like Sartorius Stedim Biotech and HOYA, its performance will also depend on international market conditions and currency fluctuations.
MDEV Top 10 Holdings
MDEV is a pure play on global medical devices, and its story right now is about a few fast climbers offsetting some notable laggards. Align Technology and Japan’s HOYA are rising smartly, helping power the fund with strong momentum in dental and optical gear, while Masimo has suddenly come back to life after a rough stretch. On the other side, Waters and Intuitive Surgical are losing steam, acting as a brake on returns. With almost everything tied to health care equipment, the ETF is both thematically focused and globally diversified.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exact Sciences | 3.75% | $70.84K | $19.77B | 130.16% | 70 Outperform | |
| Globus Medical | 3.16% | $59.76K | $11.45B | 19.33% | 82 Outperform | |
| Align Tech | 2.76% | $52.06K | $11.71B | -1.18% | 74 Outperform | |
| Penumbra | 2.72% | $51.44K | $13.19B | 23.31% | 78 Outperform | |
| HOYA | 2.71% | $51.13K | ¥9.37T | 50.12% | 74 Outperform | |
| Masimo | 2.56% | $48.44K | $9.16B | 4.33% | 54 Neutral | |
| Hologic | 2.34% | $44.25K | $16.77B | 23.74% | 76 Outperform | |
| Edwards Lifesciences | 2.33% | $44.10K | $47.52B | 18.07% | 79 Outperform | |
| Intuitive Surgical | 2.32% | $43.91K | $167.68B | -2.53% | 78 Outperform | |
| Fisher & Paykel Healthcare Corporation Limited | 2.29% | $43.17K | $22.87B | 22.23% | ― |
MDEV Technical Analysis
Negative
―
Price Trends
20.77
Negative
20.84
Negative
20.57
Negative
Market Momentum
-0.46
Positive
20.40
Positive
1.96
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MDEV, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 20.18, equal to the 50-day MA of 20.77, and equal to the 200-day MA of 20.57, indicating a bearish trend. The MACD of -0.46 indicates Positive momentum. The RSI at 20.40 is Positive, neither overbought nor oversold. The STOCH value of 1.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MDEV.
MDEV Peer Comparison
Comparison Results
Performance Comparison
MDEV
First Trust Indxx Medical Devices ETF
18.83
-1.65
-8.06%
FMED
Fidelity Disruptive Medicine ETF
―
―
―
OZEM
Roundhill GLP-1 & Weight Loss ETF
―
―
―
HRTS
Tema Cardiovascular and Metabolic ETF
―
―
―
HTEC
ROBO Global Healthcare Technology and Innovation ETF
―
―
―
MEDI
Harbor Health Care ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents